Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study
Memorial Sloan Kettering Cancer Center · University College Hospital · +24 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
878
total citations
- FWCI
- 109.32
- Percentile
- 100%
- References
- 24
Citations per year
Authors
19Topics & keywords
Topics
Keywords
- Pembrolizumab
- Microsatellite instability
- Colorectal cancer
- Medicine
- Oncology
- Internal medicine
- Chemotherapy
- Open label
No related works found for this paper.